Tarsus Pharmaceuticals, Inc. (TARS) Form 8-K — Jul 13, 2026
Tarsus Pharmaceuticals announced that Chief Commercial Officer Aziz Mottiwala will leave his position and the company effective July 15, 2026. Mottiwala is departing to become the Chief Executive Officer of a public medical device company. The filing did not disclose a successor for the departing executive.
Price after filing
1 day: -5.4%7 days: -5.2%30 days: +17.1%
Close on the filing date to close N calendar days later (from $59.31). Historical, not a forecast.
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.